Upon cell-cell contact, one of the mechanisms of immune cells to cause tissue damage is by delivery of lytic granules containing preformed effector molecules--perforin proteins and granzyme proteases. The presence of granzymes and perforin in the extracellular milieu not only reflects the presence of activated CTL and NK cells but also significantly contribute to inflammatory reaction. These protein enzymes can cause circular pore-like lesions on the membrane surface of endothelial cells and induce target cell death leading to local tissue damage and chronic vascular cell damage. Increased granzyme level is closely correlated with the inflammatory activity in autoimmune diseases (e.g. rheumatoid arthritis) and virally-infected lung and heart diseases. A clear understanding of the pathophysiology of inflammation mediated tissue damage would greatly facilitate management of this disease. The signal transduction pathways in effector lymphocytes, which trigger the redistribution of the lytic granules towards the target endothelial cells, are not well defined. Identification of key signaling molecules which specifically control this lytic process could enable pharmaceutical disruption of this process, thereby reducing the tissue damage mediated by activated lymphocytes. In this proposal, we will use a human primary pulmonary endothelial cell line, CRL- 2598, as the trigger to activate the lytic signal cascade in NK cells. Using biochemical and gene delivery approaches, we will directly test the hypothesis that the early signals via NK activation receptors and their associated adaptor proteins, DAP12 and DAP10, will play a specific role in control of granule movement in NK cells. Blocking of this initial step, at the level of the adaptor proteins, will inhibit granule exocytosis. More importantly, we will test our hypothesis on LGL leukemic patients with primary pulmonary hypertension (PPH) and determine if DAP10 and/or DAP12 critically control NK cell- mediated endothelial cell damage and death. A better understanding of the signaling pathways that control granule movement and exocytosis will offer new opportunities, e.g. design of DAP10 and DAP12 antagonists, for therapeutic intervention to specifically control lymphocyte-mediated tissue damage. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI056213-02
Application #
6884492
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Rathbun, Gary
Project Start
2004-05-01
Project End
2009-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
2
Fiscal Year
2004
Total Cost
$285,250
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Wei, S; Chen, X; McGraw, K et al. (2013) Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion. Oncogene 32:1110-20
Chen, Xianghong; Eksioglu, Erika A; Zhou, Junmin et al. (2013) Induction of myelodysplasia by myeloid-derived suppressor cells. J Clin Invest 123:4595-611
Bai, Fanqi; Villagra, Alejandro V; Zou, Jianxiang et al. (2012) Tipifarnib-mediated suppression of T-bet-dependent signaling pathways. Cancer Immunol Immunother 61:523-33
Zhou, Junmin; Eksioglu, Erika A; Fortenbery, Nicole R et al. (2011) Bone marrow mononuclear cells up-regulate toll-like receptor expression and produce inflammatory mediators in response to cigarette smoke extract. PLoS One 6:e21173
Zhou, Junmin; Wu, Jinfeng; Chen, Xianghong et al. (2011) Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol 11:890-8
Chen, Xianghong; Bai, Fanqi; Sokol, Lubomir et al. (2009) A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood 113:3226-34
Yang, Jun; Epling-Burnette, P K; Painter, Jeffrey S et al. (2008) Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 111:1610-6
Epling-Burnette, P K; Sokol, Lubomir; Chen, Xianhong et al. (2008) Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood 112:4694-8
Sallman, David A; Chen, Xianghong; Zhong, Bin et al. (2007) Clusterin mediates TRAIL resistance in prostate tumor cells. Mol Cancer Ther 6:2938-47
Wei, Sheng; Zhou, Jun-Min; Chen, Xinghong et al. (2007) The zebrafish activating immune receptor Nitr9 signals via Dap12. Immunogenetics 59:813-21

Showing the most recent 10 out of 13 publications